<
×

šŸš€ We're Here to Assist You

Master of Biopharmaceutical Engineering

Biopharmaceuticals have a critical role to play in improving global health. Recently, the development of mRNA and DNA vaccines to combat the COVID-19 pandemic has brought the work of biopharmaceutical engineers further into the public spotlight. The more effectively and efficiently these powerful vaccines or medicines can be designed and produced, the more lives they will save.



With the biopharmaceuticals market valued at approximately $325.17 billion USD in 2020, professionals with specialist biopharmaceutical engineering training are in demand worldwide. Our Master of Biopharmaceutical Engineering will prepare you to take up the challenge.

 

What will you do?

Suitable for chemical engineering and biological science graduates, as well as engineers with relevant work experience.



The first year is a blend of face-to-face and online course work. You will gain a comprehensive understanding of biopharmaceutical manufacturing’s technical, management and process engineering aspects.



In year two, you will undertake a significant research project with supervision and mentorship from one of our world-class research-active academics and/or a recognised industry expert. You will emerge with:

  • comprehensive awareness of global biopharmaceutical market demands and regulatory requirements
  • advanced knowledge and capability in state-of-the-art biopharmaceutical engineering, manufacturing and processing practice, including advanced processing technologies
  • the ability to critically reflect on appropriate use of biopharmaceutical principles and techniques, and advise others accordingly
  • deep understanding of the industry’s social and environmental impacts
  • high-level problem-solving and communication skills.

 

Where could it take you?

You will graduate ready to play a leading role in cutting-edge biopharmaceutical engineering anywhere in the world. You could help design and/or deliver next-level manufacturing and processing of therapies based on monoclonal antibodies, recombinant proteins, nucleic acids or immune cells. Your work could reduce the toll of infectious diseases, cancer, cardiovascular disease or diabetes. You may even choose to follow the masters course with research towards a PhD.